Skip to content

Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder

Optimum Frequency and Timing of Oral Iron Administration for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04610827
Enrollment
6
Registered
2020-11-02
Start date
2020-11-16
Completion date
2021-06-29
Last updated
2024-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron-deficiency, Periodic Limb Movement Sleep Disorder, Restless Legs Syndrome, Sleep Disorder

Brief summary

The purpose of this research study is to see if the level of serum ferritin differs based on how often oral iron (in the form of ferrous sulfate) is given to children with restless leg syndrome/periodic limb movement disorder.

Interventions

DRUGFerrous sulfate

Guideline-recommended 3 mg/kg/day dosing

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* Ferritin equal to or lower than 24 mcg/L drawn within the last 30 days. * Age 2 to 10 years. * Diagnosis of restless leg syndrome, periodic limb movement disorder, or sleep disturbance.

Exclusion criteria

* Currently taking oral formulation of iron other than a multivitamin. * Untreated obstructive sleep apnea. * Gastrointestinal disorder, including gastroesophageal reflux disease and celiac disease. * Prior gastrointestinal surgery; e.g., gastrectomy, duodenal bypass, and presence of G-tube. * Use of H2 blocker, antacid, or proton pump inhibitor. * Inflammatory disorders, including juvenile idiopathic arthritis or inflammatory bowel disease. * Elevated CRP at time of initial ferritin or report of illness in past 4 weeks.

Design outcomes

Primary

MeasureTime frameDescription
Ferritin Level2 monthsFerritin level in blood measured in micrograms per liter
Side Effects2 monthsNumber of subjects to experience side effects effects (e.g., stool color change, nausea, constipation, teeth staining)

Countries

United States

Participant flow

Participants by arm

ArmCount
Ferrous Sulfate Daily
Subject will take 3 mg/kg oral iron in the morning Ferrous sulfate: Guideline-recommended 3 mg/kg/day dosing
1
Ferrous Sulfate Twice Daily
Subjects will take 1.5 mg/kg oral iron twice daily Ferrous sulfate: Guideline-recommended 3 mg/kg/day dosing
2
Ferrous Sulfate Every Other Day
6 mg/kg oral iron every other day in the morning Ferrous sulfate: Guideline-recommended 3 mg/kg/day dosing
3
Total6

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyWithdrawal by Subject110

Baseline characteristics

CharacteristicTotalFerrous Sulfate Twice DailyFerrous Sulfate Every Other DayFerrous Sulfate Daily
Age, Categorical
<=18 years
6 Participants2 Participants3 Participants1 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
6 participants2 participants3 participants1 participants
Sex: Female, Male
Female
2 Participants1 Participants0 Participants1 Participants
Sex: Female, Male
Male
4 Participants1 Participants3 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 10 / 20 / 3
other
Total, other adverse events
1 / 11 / 20 / 3
serious
Total, serious adverse events
0 / 10 / 20 / 3

Outcome results

Primary

Ferritin Level

Ferritin level in blood measured in micrograms per liter

Time frame: 2 months

Population: Ferritin level at 2 months was not collected for 4 participants.

ArmMeasureValue (NUMBER)
Ferrous Sulfate Twice DailyFerritin Level24 mcg/L
Ferrous Sulfate Every Other DayFerritin Level19 mcg/L
Primary

Side Effects

Number of subjects to experience side effects effects (e.g., stool color change, nausea, constipation, teeth staining)

Time frame: 2 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ferrous Sulfate DailySide Effects1 Participants
Ferrous Sulfate Twice DailySide Effects1 Participants
Ferrous Sulfate Every Other DaySide Effects0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026